TCR2 Therapeutics Inc. (TCRR)

AI Score

Unlock

1.48

0.00 (0.00%)

At close: May 31, 2023, 8:00 PM

TCR2 Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q4 2017
Period Ending	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Dec 31, 2017
Cash & Equivalents	14.45M	32.75M	54.01M	44.21M	74.12M	222.56M	262.5M	248.79M	218.28M	94.16M	101.61M	49.7M	31.09M	65.3M	49.32M	40.98M	46.41M	47.67M	107.77M	19.81M
Short-Term Investments	95.86M	116.43M	121.98M	162.03M	158.07M	43.03M	33.24M	68.55M	115M	133.83M	145.11M	75.12M	95.02M	92.83M	111.69M	128.65M	115.25M	75.49M	23.23M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	14.54M	n/a	8.01M	11.12M	30.05M	n/a	n/a	n/a
Other Long-Term Assets	1.87M	1.94M	2.06M	2.21M	1.95M	1.89M	1.82M	1.63M	1.37M	644K	417K	648K	587K	417K	417K	290K	290K	2.3M	1.49M	310K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	8.82M	5.16M	8.09M	9.59M	15.12M	10.53M	7.48M	7.88M	9.69M	7.55M	7.51M	8.96M	6.84M	5.06M	5.61M	6.05M	3.93M	2.33M	392K	892K
Total Current Assets	140.49M	177.62M	184.08M	215.83M	247.3M	276.13M	303.22M	325.23M	342.97M	235.54M	254.23M	133.78M	132.96M	163.19M	166.62M	175.68M	165.59M	125.49M	131.39M	20.7M
Property-Plant & Equipment	9.15M	28.68M	86.79M	90M	74M	45.36M	41.68M	41.28M	51.84M	10.01M	6.2M	5.96M	5.22M	4.93M	4.46M	3.17M	1.94M	1.64M	1.79M	1.03M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	11.02M	30.61M	88.85M	92.21M	75.94M	47.24M	43.51M	42.91M	53.21M	10.66M	6.62M	6.61M	20.35M	5.34M	12.89M	14.58M	32.27M	3.94M	3.28M	1.34M
Total Assets	151.51M	208.24M	272.93M	308.04M	323.25M	323.37M	346.72M	368.14M	396.18M	246.19M	260.85M	140.38M	153.3M	168.53M	179.51M	190.26M	197.86M	129.43M	134.67M	22.04M
Account Payables	6.32M	2.79M	2.96M	5.47M	4.48M	2.14M	4.38M	4.82M	3.83M	2.45M	2.95M	2.99M	3.18M	2.48M	3.62M	4.04M	2.83M	2.66M	1.51M	427K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	3.27M	50.45M	20.55M	20.57M	16.93M	3.37M	3.48M	3.59M	2.11M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	37.88M	10.82M	13.19M	12.53M	9.45M	13.09M	8.65M	6.53M	4.58M	6.39M	4.9M	3.37M	2.95M	5.05M	4.26M	3.12M	2.53M	2.8M	2.28M	804K
Total Current Liabilities	47.47M	64.06M	36.69M	38.57M	30.87M	18.61M	16.52M	14.95M	10.52M	8.84M	7.85M	6.36M	6.13M	7.53M	7.88M	7.16M	5.36M	5.46M	3.79M	1.23M
Long-Term Debt	2.71M	3.32M	37.68M	43.21M	36.75M	23M	23.64M	24.05M	35.01M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	313K	293K	299K	257K	892K	807K	635K	609K	583K	546K	474K	464K	455K	209.66M	412K	47.13M
Total Long-Term Liabilities	2.71M	3.32M	37.68M	43.21M	37.06M	23.29M	23.93M	24.3M	35.9M	807K	635K	609K	583K	546K	474K	464K	455K	209.66M	412K	47.13M
Total Liabilities	50.18M	67.38M	74.38M	81.78M	67.93M	41.89M	40.45M	39.25M	46.42M	9.65M	8.49M	6.97M	6.71M	8.08M	8.36M	7.62M	5.81M	215.13M	4.2M	48.36M
Total Debt	5.98M	53.76M	58.23M	63.78M	53.68M	26.36M	27.12M	27.64M	37.13M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	4K	4K	4K	4K	4K	4K	4K	4K	4K	3K	3K	2K	2K	2K	2K	2K	2K	n/a	2K	n/a
Retained Earnings	-541.74M	-501.34M	-440.84M	-410.25M	-378.64M	-349.52M	-321.78M	-295.54M	-271.23M	-249.72M	-231.26M	-214.34M	-198.1M	-182.59M	-169.76M	-155.96M	-144.9M	-85.59M	-75.03M	-26.32M
Comprehensive Income	-188K	-445K	-596K	-671K	-344K	-13K	-15K	-19K	-44K	63K	191K	402K	-462K	142K	230K	212K	1K	-106K	-3K	n/a
Shareholders Equity	101.33M	140.86M	198.55M	226.26M	255.32M	281.48M	306.27M	328.89M	349.75M	236.55M	252.36M	133.41M	146.59M	160.45M	171.15M	182.64M	192.05M	-85.7M	130.46M	-26.32M
Total Investments	95.86M	116.43M	121.98M	162.03M	158.07M	43.03M	33.24M	68.55M	115M	133.83M	145.11M	75.12M	109.56M	92.83M	119.7M	139.77M	145.3M	75.49M	23.23M	n/a